Khandelwal Laboratories

Mumbai, India Founded: 1945 • Age: 81 yrs Minicorn
APIs and formulations are manufactured, focusing on oncology treatments.
Request Access
Report Incorrect Data
Page last updated

About Khandelwal Laboratories

Khandelwal Laboratories is a Healthcare company based in Mumbai (India) founded in 1945. APIs and formulations are manufactured, focusing on oncology treatments. The company has 810 employees. Khandelwal Laboratories was last valued at $1.16 million in March 2007. Its Indian entity Khandelwal Laboratories Private Limited reported revenue of ₹240 Cr. Khandelwal Laboratories offers products and services including Oncology Products, Antibiotics, Niche APIs, and NDDS Formulations. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.

Company details

Khandelwal Laboratories manufactures, markets and out-licenses patented pharmaceutical formulations, NDDS, APIs and chiral intermediates. It is marketing its generic products in various therapeutic segments such as anaesthetics, antihypertensives, anti- ulcer agents, antiasthmatic, anti-diabetic, anti-fungal, antihistamines, antimicrobials, NSAIDs etc. It also manufactures APIs, formulations (branded generics) for oncology treatment and also offers CMO services. Their WHO GMP approved manufacturing facility is capable of manufacturing tablets, capsules and injections (liquids and lyophilized). The company claims to have 222 patents (granted and pending) in the areas of NDDS, nanotechnology, dendrimers and chiral chemistry.

Operational Areas
Healthcare → Biopharma Outsourcing & Drug Delivery
Key Metrics
  • Annual Revenue
    ₹240 Cr

    FY 2025 · +2% YoY

  • Net Profit
    ₹6.00 Cr

    FY 2025 · 2% margin

  • EBITDA
    ₹11.91 Cr

    FY 2025 · 5% margin

  • Latest Funding Round
    $459.28K (USD), Unspecified

    Mar 2007

  • Employee Count
    810

Products & Services of Khandelwal Laboratories

Khandelwal Laboratories offers a comprehensive portfolio of products and services, including Oncology Products, Antibiotics, Niche APIs, and NDDS Formulations.

Oncology Products
Pharmaceuticals

Drugs for cancer treatment and management in patients.

Antibiotics
Pharmaceuticals

Medications to combat bacterial infections effectively.

Niche APIs
Pharmaceuticals

Active ingredients for specialized drug formulations.

NDDS Formulations
Pharmaceuticals

Advanced delivery systems for targeted drug administration.

Funding Insights of Khandelwal Laboratories

  • Total Rounds 1
  • Last Round Unspecified — $459,284
  • First Round $459,284

    (Mar 2007)

  • Investors Count 1

All 1 funding rounds of Khandelwal Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2007$459,284Unspecified$1.16MSanjeev Khandelwal
–
Valuation history
DateValuationStage
Mar 2007$1.16M••••••••

Last known valuation $1.16M (Mar 2007). 1 investors in total: 0 institutional and 1 angel.

Investors in Khandelwal Laboratories

Khandelwal Laboratories has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Sanjeev Khandelwal.

All
Angel
InvestorDescriptionFounded YearDomainLocation

Sanjeev Khandelwal

unknown_8b86ebdce93b4b778
Premium access

Investor details for Khandelwal Laboratories

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Khandelwal Laboratories Private Limited (Khandelwal Laboratories)

Khandelwal Laboratories Private Limited is the primary company behind Khandelwal Laboratories. The boards of the 2 registered companies of Khandelwal Laboratories currently have 7 directors; the longest-serving is Vijay Kumar Goel, appointed in 1993. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vijay Kumar Goel
DIN 00075317
Director18 Jun 199333 yrs 4 moKhandelwal Laboratories Private Limited
Sanjeev Khandelwal
DIN 00098800
Director20 Aug 199333 yrs 2 moKhandelwal Laboratories Private Limited
Puneet Subhash Wadhwa
DIN 00073011
Director30 Aug 200620 yrs 2 moNano Cutting Edge Technology Private Limited
Subhash Kashinath Pai Kakode
DIN 00073004
Director01 Mar 201115 yrs 8 moKhandelwal Laboratories Private Limited
Anuradha Sanjeev Khandelwal
DIN 00158579
Director01 Oct 201610 yrs 1 moKhandelwal Laboratories Private Limited
Sunita Khandelwal
DIN 00098806
Director01 Oct 201610 yrs 1 moKhandelwal Laboratories Private Limited
Arun Ravindranathan Nair
DIN 08554211
Director04 Sep 20197 yrs 2 moNano Cutting Edge Technology Private Limited

People of Khandelwal Laboratories

13 people are tracked at Khandelwal Laboratories (4 in leadership, 9 in team); the tracked headcount is 810.

NameRoleGroup
Sanjeev Khandelwal
Managing DirectorLeadership
P. Omray
Technical DirectorLeadership
G. Pinto
Vice President FinanceLeadership
S. K. Pai Kakode
DirectorLeadership
Mukesh Khanna
Zonal Sales ManagerTeam
Jayant Talawadekar
Sr. Quality Assurance ManagerTeam
Apurba Dutta
Regional Business ManagerTeam
Saroj Mohite
Product ExecutiveTeam
Sunil Kumar
ManagerTeam
Manu Dev
Production ExecutiveTeam
S. Sharma
International LicensingTeam
Rangarao Pinakana
ManagerTeam
Sunil Israni
ManagerTeam
Premium access

Complete people profiles for Khandelwal Laboratories

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Khandelwal Laboratories

Figures of Khandelwal Laboratories Private Limited, the primary company behind Khandelwal Laboratories, for FY 2025. Revenue was ₹240 Cr (+2% year on year). Net profit was ₹6.00 Cr (2% margin). EBITDA was ₹11.91 Cr (5% margin). Revenue has grown at a compounded annual rate of +7% over three years and +1% over five years.

  • ₹240 CrRevenue · FY 2025 · +2% YoY
  • ₹6.00 CrNet profit · 2% margin
  • ₹11.91 CrEBITDA · 5% margin
  • ₹5.00 CrPaid-up capital
  • 810Employees (provident fund records)
  • +7%Revenue CAGR, 3 years
  • +1%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Khandelwal Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for Khandelwal Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Khandelwal Laboratories

3 dated milestones of Khandelwal Laboratories across 62 years, from founding to its latest funding, stage changes and deals.

  1. Founded Khandelwal Laboratories is founded.
  2. Funding First funding round of $459K.
  3. Milestone Reaches Minicorn status.

Competitors of Khandelwal Laboratories

Khandelwal Laboratories has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Indoco Remedies
indoco.com1947Mumbai, India6,291
APIs manufacturing and formulation services are provided in therapeutic segments.
Concord Biotech
concordbiotech.com2000Ahmedabad, India1,598
APIs and enzymes are manufactured through fermentation by the CDMO.
BDR Pharmaceuticals Internationals
bdrpharma.com2003Mumbai, India$88.16M1,864
APIs and finished products are developed and manufactured.
Premium access

Detailed competitors of Khandelwal Laboratories

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Khandelwal Laboratories

The website of Khandelwal Laboratories (khandelwallab.com) receives about 6.5K visits a month.

  • Monthly visits
    6.5K
Similar websites

Websites whose visitors overlap most with Khandelwal Laboratories. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
sspharmachem.com
sspharmachem.com
100%
–
Rishabh Intermediates
porwal.net
100%
1.1K#14,642,220View details
Luna Chemicals
lunachem.com
100%
#13,996,556View details
hengshunchem.com
hengshunchem.com
100%
–
gayatrionline.com
gayatrionline.com
100%
–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 15 similar websites and full traffic analytics for Khandelwal Laboratories

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Khandelwal Laboratories (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Anthem Biosciences
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Laurus Labs
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Entero Healthcare
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Khandelwal Laboratories

Aurobindo Pharma subsidiary acquires Khandelwal Laboratories’ non-oncology prescription business for ₹325 cr - CNBC TV18
CNBCTV18 • 10 months ago
Premium access

Complete news archive for Khandelwal Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Khandelwal Laboratories

Khandelwal Laboratories was founded in 1945 and raised its 1st funding round 62 years after it was founded.

Khandelwal Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Khandelwal Laboratories has 810 employees.

The primary company behind Khandelwal Laboratories, Khandelwal Laboratories Private Limited, reported revenue of ₹240 Cr for FY 2025, up 2% year on year.

Khandelwal Laboratories manufactures, markets and out-licenses patented pharmaceutical formulations, NDDS, APIs and chiral intermediates. It is marketing its generic products in various therapeutic segments such as anaesthetics, antihypertensives, anti- ulcer agents, antiasthmatic, anti-diabetic, anti-fungal, antihistamines, antimicrobials, NSAIDs etc. It also manufactures APIs, formulations (branded generics) for oncology treatment and also offers CMO services. Their WHO GMP approved manufacturing facility is capable of manufacturing tablets, capsules and injections (liquids and lyophilized). The company claims to have 222 patents (granted and pending) in the areas of NDDS, nanotechnology, dendrimers and chiral chemistry.

Khandelwal Laboratories's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.

Khandelwal Laboratories offers Oncology Products, Antibiotics, Niche APIs, and NDDS Formulations.

Khandelwal Laboratories has 1 investor. Key investors include Sanjeev Khandelwal.

The valuation of Khandelwal Laboratories is $1.16M as of Mar 2007.

Khandelwal Laboratories is associated with 2 legal entities: Khandelwal Laboratories Private Limited, Nano Cutting Edge Technology Private Limited.

The legal entities of Khandelwal Laboratories currently have 7 directors, including Puneet Subhash Wadhwa, Arun Ravindranathan Nair, Anuradha Sanjeev Khandelwal and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available